|
03/08/2010 03:00 AM
|
|
Michael J. Fox To Be Made Honorary Doctor At Karolinska Institutet
|
Since 2000, the foundation has awarded over 175 million dollars to Parkinson's drug development research around the world, including at Karolinska Institutet. Michael J. Fox is to receive his honorary doctorate on 5 March from Associate Professor and Dean Clara H. Gumpert representing the Board of Research, which selects the honorary doctors at Karolinska Institutet...
|
|
03/05/2010 04:00 AM
|
|
Psychosurgery Makes Gentle Comeback
|
Psychosurgery is making a comeback. Recently published case series have shown encouraging results of so-called deep brain stimulation (DBS) in treatment-resistant obsessive-compulsive disorder, depressive disorders, and Tourette syndrome...
|
|
03/04/2010 04:00 AM
|
|
Parkinson's Disease Makes It Harder To Figure Out How Other People Feel
|
Scientists are beginning to find out why people with Parkinson's disease often feel socially awkward. Parkinson's patients find it harder to recognize expressions of emotion in other people's faces and voices, report two studies published by the American Psychological Association...
|
|
03/03/2010 01:00 AM
|
|
Michael J. Fox Foundation Awards Mayo Clinic Researcher Grant To Advance Parkinson's Disease Research
|
For his work contributing to a potential new treatment approach for Parkinson's disease, the Michael J. Fox Foundation (MJFF) for Parkinson's Research has awarded a $500,000 grant to a neuroscientist at the Mayo Clinic campus in Florida. The researcher, Matthew Farrer, Ph.D...
|
|
03/03/2010 12:00 AM
|
|
Neuroscientist Steers Research Into Neurological Disorders
|
Scientists at the Queensland Brain Institute have uncovered a vital clue into how the brain is wired, which could eventually steer research into nervous system disorders such as Parkinson's disease and cognitive disorders including autism. It's long been known that growing nerve fibres, also known as axons, must make connections in the brain for it to function properly...
|
|
03/02/2010 12:00 AM
|
|
Researchers Take Next Step In Developing Parkinson's Disease Vaccine
|
Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease. The findings appear in the March 1 issue of the Journal of Immunology, a leading scientific journal in the field of immunology...
|
|
02/23/2010 01:00 AM
|
|
FDA Approves Once-Daily MIRAPEX ER For The Treatment Of Early Parkinson's Disease
|
Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD...
|
|
02/18/2010 05:00 AM
|
|
Biophysicists Show That 'Incomplete Penetrance' Is Not Just A Question Of Nature Versus Nurture
|
For years, biologists have wondered how it is possible that not every person who carries a mutated gene expresses the trait or condition associated with the mutation. This common but poorly understood phenomenon, known as incomplete penetrance, exists in a wide range of organisms, including humans...
|
|
02/18/2010 12:00 AM
|
|
An Ibuprofen A Day Could Keep Parkinson's Disease Away
|
New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson's disease, according to a study released that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. The research involved 136,474 people who did not have Parkinson's disease at the beginning of the research...
|
|
02/16/2010 12:00 AM
|
|
Researchers Firm-Up Evidence For Role Of Mitochondria In Parkinson's Disease
|
A new study from the National Institutes of Health sheds light on the functions of two proteins related to Parkinson's disease, called parkin and PINK1...
|
|
02/12/2010 01:00 AM
|
|
Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study Of Amigal(TM) For Fabry Disease
|
Amicus Therapeutics (Nasdaq: FOLD) announced additional positive preliminary data from its ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease at the Lysosomal Disease Network WORLD Symposium in Miami, Florida...
|
|
02/10/2010 04:00 AM
|
|
Nerve Cells In Parkinson's Disease Suffer Communication Breakdown
|
A new study from The Montreal Neurological Institute and Hospital - The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate...
|
|
02/08/2010 03:00 AM
|
|
Industrial Cleaner Linked To Increased Risk Of Parkinson's Disease
|
Workers exposed to tricholorethylene (TCE), a chemical widely used to clean metal such as auto parts, may be at a significantly higher risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010...
|
|
02/06/2010 12:00 AM
|
|
TGen Finalizes Alliance With Van Andel Research Institute
|
The Translational Genomics Research Institute (TGen) has announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes...
|
|
02/03/2010 05:00 AM
|
|
The Quick And The Dead: Evidence That Movement Is Swiftest In Response To Events In The Environment
|
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust at the University of Birmingham have carried out "laboratory gunfights" to show that we move faster when we react to something in our environment than we do when we initiate the action ourselves- an idea inspired by cowboy movies but in reality more useful for avoiding oncoming traffic...
|
|
02/03/2010 03:00 AM
|
|
Parkinson's Disease Research Uncovers Social Barrier
|
People with Parkinson's disease suffer social difficulties simply because of the way they talk, a McGill University researcher has discovered. Marc Pell, at McGill's School of Communication Sciences and Disorders, has learned that many people develop negative impressions about individuals with Parkinson's disease, based solely on how they communicate...
|
|
02/03/2010 01:00 AM
|
|
Simulation Study May Help Parkinson's Patients Retain Driving Skills
|
In a first-of-its-kind study, Medical College of Georgia researchers are testing whether simulation driving can reduce Parkinson's patients' threefold increased risk of car accidents. Drivers with Parkinson's disease are three times more likely to have a car accident than healthy drivers because of cognitive, motor and visuospatial impairments...
|
|
02/01/2010 09:00 AM
|
|
Gordon Brown Receives Prescription Promise 'Wake-Up Call', UK
|
People across England will be joining forces to demonstrate their outrage at Gordon Brown's failure to act on his promise to abolish prescription charges for people with long-term conditions, by taking part in a simultaneous 'wake-up phone call' to No 10...
|
|
02/01/2010 07:00 AM
|
|
Synosia Announces Positive Interim Results For Potential First-in-Class Treatment For Parkinson's Disease
|
Synosia Therapeutics announced interim positive data from a Phase IIa clinical study of an adenosine 2a (A2a) receptor antagonist (SYN115) in Parkinson's disease. The Phase IIa trial was a randomised, double-blind, placebo-controlled, cross-over study in 24 Parkinson's patients using doses up to 120mg/day for one week...
|
|
01/28/2010 02:00 AM
|
|
Parkinson's Rates Highest In Whites, Hispanics
|
The largest epidemiological study of Parkinson's disease in the United States has found that the disease is more common in the Midwest and the Northeast and is twice as likely to strike whites and Hispanics as blacks and Asians...
|
|
01/28/2010 12:00 AM
|
|
'Deep Brain Stimulation' For Parkinson's Disease: Study By Scott & White Healthcare Researchers
|
At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS)...
|
|
01/28/2010 12:00 AM
|
|
Lefkowitz, BBVA Foundation Frontiers Of Knowledge Award In Biomedicine
|
The BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category goes in this second edition to Prof. Robert J. Lefkowitz (1943, New York, United States), investigator in the Department of Medicine at Duke University (United States)...
|
|
01/26/2010 05:00 AM
|
|
The Emergence Of A New Class Of Brain-Protecting Drugs
|
Researchers have identified a compound that mimics one of the brain's own growth factors and can protect brain cells against damage in several animal models of neurological disease. 7,8-dihydroxyflavone is a member of the flavonoid family of chemicals, which are abundant in fruits and vegetables...
|
|
01/25/2010 01:00 AM
|
|
Study Finds Common Heart Medications May Also Protect Against Parkinson's Disease
|
UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson's disease. In the first large-scale population-based study of its kind, Dr...
|
|
01/23/2010 12:00 AM
|
|
Discovery Of Stroke's 'Death Signal' May Aid Drug Development
|
Biomedical scientists from the University of Central Florida and Louisiana State University have identified a way to block a "cell death signal" that they believe triggers brain damage during strokes. Strokes, also known as cerebral ischemia, are caused by inadequate blood flow to the brain and are the third-leading cause of death in the United States...
|
